The Best Practice Organization: Key to Success in Today’s Biopharma Industry

1. Operational Excellence: Biopharma companies must master a broad set of technical and operational capabilities to succeed, including lean, agile, and efficient manufacturing, as well as the ability to quickly and reliably produce personalized medicines and high-volume, low-cost manufacturing capabilities.
2. Business Development Strategy: Effective business development involves prioritizing goals, building relationships with targets, and agreeing on how to accomplish objectives. It also includes strategies such as divestitures, spin-offs, and ecosystem plays to drive scale and cost efficiencies.
3. Talent Strategy: Leading biopharmas focus on developing competencies, traits, and drivers for MSLs and leaders to produce superior physician experiences. They also assess critical roles against strategic, business, and role value to identify hidden talent.
4. Medical Affairs: Biopharmas should rebalance medical and commercial field team composition to unlock physician access and safeguard launch success. Engaging key opinion leaders pre-launch can lead to higher treatment adoption rates.
5. Generative AI: Top companies achieve greater ROI on generative AI investments by tackling governance early and prioritizing use cases that solve employee problems. This can lead to significant increases in prescribing and HCP-agreed actions.
6. Integrated Teams: Best practice biopharmas achieve significant benefits by integrating medical and commercial field teams, leading to increased touchpoints, higher HCP satisfaction, and faster time to market.
7. Leadership and Culture: Organizations with a radically human focus on leadership, culture, team dynamics, and talent experience higher engagement, better team performance, and more profit, ultimately delivering life-saving medicines faster.